Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008
Background: More than 100,000 patients have been treated, since the implementation of the National Universal Coverage for antiretroviral therapy (ART) in Thailand. Although there are several comprehensive guidelines available internationally, there is a need to have guidelines that can be implemente...
Saved in:
Main Authors: | Somnuek Sungkanuparph, Thanomsak Anekthananon, Narin Hiransuthikul, Chureeratana Bowonwatanuwong, Khuanchai Supparatpinyo, Piroon Mootsikapun, Ploenchan Chetchotisakd, Sasisopin Kiertiburanakul, Somsit Tansuphaswadikul, Wanchai Buppanharun, Weerawat Manosuthi, Wichai Techasathit, Winai Ratanasuwan, Woraphot Tantisiriwat, Surapol Suwanagool, Manoon Leechawengwongs, Kiat Ruxrungtham |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=58949084547&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60571 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008
by: Somnuek Sungkanuparph, et al.
Published: (2018) -
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008
by: Sungkanuparph S., et al.
Published: (2014) -
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
by: Weerawat Manosuthi, et al.
Published: (2018) -
Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis
by: Somnuek Sungkanuparph, et al.
Published: (2018) -
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir
by: Weerawat Manosuthi, et al.
Published: (2018)